C85.29
Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Mediastinal large B-cell lymphoma, classified under ICD-10 code C85.29, is a specific type of non-Hodgkin lymphoma that originates from B-lymphocytes, a kind of white blood cell involved in immune response. This form of lymphoma primarily occurs in the mediastinum, the central area of the chest that separates the lungs and contains vital structures like the thymus, lymph nodes, and blood vessels. Uniquely, this lymphoma can develop outside of lymph nodes, affecting other organs and tissue in the body, and is characterized by large malignant B-cells that proliferate rapidly. It often presents as a solid tumor mass in the mediastinal space and is considered an aggressive form of lymphoma requiring timely diagnosis and treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting B-cell development and regulation Exposure to certain environmental factors such as chemicals or radiation Immunodeficiency conditions that impair immune surveillance Infections that may trigger immune dysregulation Family history of lymphoid malignancies
Key Symptoms: Persistent cough or wheezing Chest pain or pressure Shortness of breath Swelling or a noticeable lump in the chest area Unexplained weight loss Fever and night sweats Fatigue or weakness Recurring infections due to immune system impairment
Diagnostic & Treatment
Diagnosis Path: Diagnosing mediastinal large B-cell lymphoma involves several steps: - Physical examination focusing on chest and lymph nodes - Imaging studies such as chest X-ray, CT scan, or PET scan to identify tumor size and location - Biopsy procedures, including needle biopsy or surgical biopsy, to obtain tissue samples for microscopic and immunophenotypic analysis - Blood tests to assess overall health and detect abnormalities - Laboratory tests to evaluate tumor markers, if applicable This comprehensive approach helps confirm the diagnosis and determine the extent of the disease.
Treatment Protocols: Treatment options for mediastinal large B-cell lymphoma typically include: - Chemotherapy using combination regimens to target rapidly dividing cancer cells - Immunotherapy, such as monoclonal antibodies, to enhance the immune system's ability to fight the lymphoma - Radiation therapy to target specific tumor sites - Targeted therapy, in some cases, focusing on specific molecular features of the cancer - Stem cell transplant, considered in cases of relapse or resistant disease The choice of treatment depends on factors like disease stage, patient health, and response to initial therapies, and is tailored to maximize effectiveness while managing side effects.
Clinical Advice & FAQs
Billing Guidance
Is C85.29 a billable ICD-10 code?
Yes, C85.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.29?
Clinical documentation must specify the nature of Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference